Pharmaceutical and medicine manufacturing R&D funded by other external sources
RecordSTO-1T62KC55PB-N17E6MAPSH-2EP2XC
United States · 2023
Pharmaceutical and medicine manufacturing R&D funded by other external sources in the United States was 79 million USD in 2023 (NCSES).
Pharmaceutical R&D investment in United States: every year, the rank and how it is measured
- Publisher
- NCSES
- Authority tier
- T1 Official
- Locator
- Table 2. Funds spent for business R&D performed in the United States, by source of funds, selected industry, and company size: 2023
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
Pharmaceuticals and medicines, 3254 125,986 empty 114,225 empty 11,761 empty 549 empty 2,104 empty 9,029 empty 79 empty
Checked: the figure 79 million USDis stated in this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
APA
National Center for Science and Engineering Statistics. (2023). Business R&D Performance in the United States Increases to $722 Billion in 2023. Retrieved September 17, 2026, from https://ncses.nsf.gov/pubs/nsf25353. Via StatOrigin, https://statorigin.org/stat/stat_1T62KC55PBN17E6MAPSH2EP2XC
Other formats: MLA, Chicago, BibTeX
- MLA
- National Center for Science and Engineering Statistics. "Business R&D Performance in the United States Increases to $722 Billion in 2023." 2023, https://ncses.nsf.gov/pubs/nsf25353. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_1T62KC55PBN17E6MAPSH2EP2XC.
- Chicago
- National Center for Science and Engineering Statistics. "Business R&D Performance in the United States Increases to $722 Billion in 2023." 2023. https://ncses.nsf.gov/pubs/nsf25353. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_1T62KC55PBN17E6MAPSH2EP2XC.
- BibTeX
- @misc{ncses2023pharmaceutical2ep2xc, author = {{National Center for Science and Engineering Statistics}}, title = {Business R\&D Performance in the United States Increases to \$722 Billion in 2023}, year = {2023}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_1T62KC55PBN17E6MAPSH2EP2XC}, note = {Original source: https://ncses.nsf.gov/pubs/nsf25353. Accessed September 17, 2026.} }
Data published under CC BY 4.0. The citation credits the original publisher and links to this permanent record.
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary source
- Publisher
- National Center for Science and Engineering Statistics · homepage ↗
- Authority tier
- Tier 1 · Multilateral Official
- Report
- Business R&D Performance in the United States Increases to $722 Billion in 2023
- Type
- Press release
- Published
- —
- Locator
- Table 2. Funds spent for business R&D performed in the United States, by source of funds, selected industry, and company size: 2023
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification
- Status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Permanent URL
- /stat/stat_1T62KC55PBN17E6MAPSH2EP2XC